Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of biologically active compounds targeting central nervous system disorders and metabolic diseases. Its chiral structure with fluorine substitution enhances binding selectivity and metabolic stability in drug candidates. Commonly employed in the preparation of protease inhibitors and receptor modulators due to the constrained piperidine scaffold, which improves pharmacokinetic properties. The tert-butyloxycarbonyl (Boc) protecting group allows for selective amine functionalization during multi-step syntheses, making it valuable in medicinal chemistry and process development.